Kayla Tormohlen graciously thanking all of those engaged in her training! Dept of Mental Health at BSPH Johns Hopkins Bloomberg School of Public Health

And some great Baltimore pics! Great job! Dept of Mental Health at BSPH Johns Hopkins Bloomberg School of Public Health Kayla Tormohlen

Woo hoo! Dr. Kayla Tormohlen in the house! Amazing dissertation defense: “Role of depression in health care service utilization and opioid agonist treatment among persons with co-occurring opioid use and depressive disorders”. Looking forward to you as a Dept of Mental Health at BSPH alum!

And a future @JHSPH_HPM faculty member! Congrats Kayla Tormohlen

Our new blog post in Health Affairs argues permanent #buprenorphine initiation via telephone is critical for assuring #healthequity and preventing #overdose. Please read and join our sign-on letter to federal officials here bit.ly/33hsZWF

🚨We're hiring analysts Hopkins Business of Health Initiative🚨 (thread below)! Come work on exciting, policy-relevant projects at the intersection of health economics, health services, and behavioral health research! (Please consider RT-ing/amplifying!!)

1/6 Our study in Annals of Int Med shows that state medical cannabis laws implemented from 2016-2019 had no effects on receipt of opioid or nonopioid pain treatment among commercially insured patients with chronic noncancer pain acpjournals.org/doi/10.7326/M2…

Disruptions in opioid use disorder treatment were marginal during the COVID-19 pandemic among patients receiving treatment pre-pandemic. Kayla Tormohlen bit.ly/3OiktPT

Happy to see our paper our in Psych Services---thank you Kayla Tormohlen for leading us! And thank you NIDAnews for generous funding support. Beth McGinty Elizabeth Stuart @admccourt Luis E. Quintero

Our new study shows minimal pandemic disruptions to continued opioid use disorder treatment among people recieving treatment pre-pandemic. Suggests telehealth and other policies to minimize Tx disruptions may have helped. Kayla Tormohlen Matthew Eisenberg Elizabeth Stuart NIDAnews

Dr. Beth McGinty and team conducted a policy analysis which found that medical cannabis laws have a negligible impact on opioid prescribing, according to a study published in Annals of Internal Medicine. tinyurl.com/4wchc45s Beth McGinty Annals of Int Med

Great info from Kayla Tormohlen and others showing that disruptions in opioid use disorder treatment were marginal during the COVID pandemic among patients receiving treatment pre-pandemic, likely because of increased telehealth utilization. ps.psychiatryonline.org/doi/full/10.11…

Postdoc alert! Interested in mental health & substance use policy & econ? Come work with me and a fabulous team in the division of health policy and economics Weill Cornell Medicine Population Health Sciences phs.weill.cornell.edu/about-us/caree…

Thanks ASAM and Greg Rudolf for the opportunity to present new findings on cannabis and pain treatments at #ASAM2024 today 👏 >340 attendees, stellar faculty, and a great pre-course on pain and addiction 👍 Key studies from our NIDAnews R01 led by Beth McGinty ⤵️ 🔗

Center for Mental Health and Addiction Policy postdoc Yimin Ge did a great job presenting her poster on the use of telemedicine in treating opioid use disorder at #ARM24. Thank you NIDAnews for funding! (ft. Kayla Tormohlen Matthew Eisenberg in addition to first author Yimin Ge!)

New in JAMA Network Open ➡️How much support exists to expand access to #cannabis for chronic pain? - Most pain patients, physicians favor federal legalization - But low support among docs who don't recommend its use Kudos to @elizmstone Kayla Tormohlen Beth McGinty 👏

New center: Weill Cornell Medicine and Cornell Jeb E. Brooks School of Public Policy have established the Cornell Health Policy Center, which will serve as the locus for health policy impact, research and training across Cornell University. Robert Harrington Colleen L. Barry Beth McGinty news.cornell.edu/stories/2024/1…

A proposed rule from the DEA will require an in-person visit with a clinician before tele-initiation of buprenorphine. In JAMA Network Open, Beth McGinty, Dr. Jiani Yu,  Kayla Tormohlen, and colleagues from Johns Hopkins Bloomberg School of Public Health assess the potential impact: bit.ly/3FiQHsl

In a study in JGIM Journal of General Internal Medicine, Sarah.Gutkind, Beth McGinty, and Kayla Tormohlen determine what informs physician perceptions and practices related to medical cannabis for chronic pain management: bit.ly/4caxOUI